Value-based care isn’t just on the way. It’s already here. Today's conversation surrounds "value-based care and outcomes." "Real World Evidence" and "reimbursement." There’s a lot to contend with: increasing numbers of stakeholders, changing regulatory guidance (with all its regional variations), the influence of social media, and the movement toward highly complex and specialized therapies. All these factors are reshaping how medicine is practiced.
To succeed in this environment, many biopharmaceutical companies are undertaking transformational initiatives to better engage a breadth of stakeholders with timely and relevant value-added products and services. While transformational initiatives may be required, there are places to start that build on resources, capabilities and competencies currently existing within Medical Affairs.
One key element is to optimize the timeliness of input and the impact of existing customer-facing roles. The biopharmaceutical industry has an opportunity to improve all of these by elevating and strategically integrating Medical Affairs within product and value proposition development and as a critical launch.
メディカル・トランスフォーメーション・ソリューションは戦略を実行に移します。
多くの組織はメディカル・トランスフォーメーションを開始、あるいは実施中です。目標達成にあたり複雑化し、クロスファンクショナルになっていく環境下において、実施に不可欠な専門性や専任リソースの必要性を認識し始めています。
We have developed a modular Medical Transformation Solution that accelerates strategy into action. Our modular solution allows customers to see what “good” looks like, assess where they are in their own journey, and how, through partnership, we can accelerate their path to success, leading to a true competitive advantage.
メディカル・ナラティブ
- 科学をその環境内に位置づけ、各外部ステークホルダーと彼らの各ニーズを定義したうえで、競合環境内での差別化要因を特定します。
エビデンス・マトリックス
- エビデンスのニーズを定義し、エビデンス上のギャップを特定し、エビデンスの可用性のタイミングと優先順位の状況を説明します。
インサイト
- These create a system and processes to ensure both a push and pull on value-driven, actionable insights for all internal and external stakeholders. Insights also set an external stakeholder perception baseline.
包括的なステークホルダー・エンゲージメント戦略
- This ensures the medical narrative informs the strategy across all Medical Affairs functions. This includes strategies to engage stakeholders through excellence in publication planning, field medical teams, global medical information, congress planning and evidence generation.
メディカル・オペレーショナル・エクセレンス
- メディカル戦略や上市計画、医療組織の卓越性、組み込まれたグローバル・メディカル情報、フィールド・メディカルチーム、人材管理/専門能力の開発、トレーニング、及びそれぞれのメトリックスが含まれます。
以下の関連コンテンツにアクセスしてください。
